The pharmaceutical company Merck, which sells the anti-bone-loss drug Fosamax, estimated in 2003, from its own market research, that about 8 million women had been found to have osteopenia and about a third of them were taking an osteoporosis drug.
The pharmaceutical company Merck, which sells the anti-bone-loss drug Fosamax, estimated in 2003, from its own market research, that about 8 million women-ERR, WHERE? CAN WE HAVE A PROPER STATEMENT?-had been found to have osteopenia and about a third of them were taking an osteoporosis drug.